Autopsy report · NCT05523310

Observational Study to Assess Migraine Prediction Tool

“The Sponsor decided to cancel the study due to commercial considerations”

The sponsor’s own words in the registry.

Life of this trial

• Suspended: paused, and may or may not restart.
• 200 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Sponsor

Theranica

Sponsor type

Industry

Conditions

Migraine

Interventions

Daily questionnaire

Participants

200 (planned, not actual)

Sites

3

Countries

United States

Trials that died the same way

• Developing Affective HeaLth to Improve Adherence to Health Behaviors in Diabetes (DAHLIA II)
  “The Sponsor chose to terminate this study for commercial reasons.” (88% match in meaning)
• Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer Patients
  “Study was cancelled by Sponsor.” (88% match in meaning)
• Study of RP-6306 With FOLFIRI in Advanced Solid Tumors
  “Sponsor decided to terminate the study” (86% match in meaning)
• the Health Crisis at the Healthcare Professionals, Careers and Non-careers, a Month After the Containment Period
  “the sponsor decided to stop the study” (86% match in meaning)
• Multi-center Complex Atrial Tachycardia High-Resolution Mapping Registry (MATH)
  “The sponsor has decided to stop the study” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.